Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Predictive Value of the Aβ Peptides Salivary Dosage for Alzheimer's Disease Diagnosis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02864303
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:21.569442+00:00
Published At
2021-12-28T00:00:00+00:00
Record Updated At
2021-12-28
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Alzheimer\u0027s Disease", "Mild Cognitive Impairment"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-12-28"
protocolSection.identificationModule.nctId
"NCT02864303"
protocolSection.identificationModule.officialTitle
"Predictive Value of the A\u03b2 Peptides Salivary Dosage for Alzheimer\u0027s Disease Diagnosis"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Alzheimer's Disease (protocolSection.conditionsModule.conditions)
  • Mild Cognitive Impairment (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.